INSIDER · CIK 1995218
Townsend Richard Nolan
Chief Executive Officer, Director at Lexeo Therapeutics, Inc. (LXEO)
↗2 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$17KSold on the market
1Companies
Sep 28, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 28, 202617:15 | Sep 14, 2026 | LXEOLexeo Therapeutics, Inc. | Chief Executive Officer, Director | A · GrantLate 14d | $2.64 | +2,306 | 376,778 | +1% | $6K | ||
| Aug 19, 202617:00 | Aug 18, 2026 | LXEOLexeo Therapeutics, Inc. | Chief Executive Officer, Director | S · Sell | $4.95 | −3,345 | 374,472 | -1% | −$17K |